DPP-4 Inhibition and Thiazolidinedione for Diabetes Mellitus Prevention (DInT DM Study).

Trial Profile

DPP-4 Inhibition and Thiazolidinedione for Diabetes Mellitus Prevention (DInT DM Study).

Discontinued
Phase of Trial: Phase III

Latest Information Update: 04 Dec 2013

At a glance

  • Drugs Pioglitazone (Primary) ; Sitagliptin (Primary)
  • Indications Diabetes mellitus; Glucose intolerance
  • Focus Therapeutic Use
  • Acronyms DInT DM
  • Most Recent Events

    • 01 May 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 26 Jul 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 23 Jun 2011 Planned initiation date changed from 1 Jul 2010 to 1 Aug 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top